CDMO
Avid Bioservices, Inc. Common Stock
CDMO
CDMO
Delisted
CDMO was delisted on the 4th of February, 2025.
169 hedge funds and large institutions have $907M invested in Avid Bioservices, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 65 increasing their positions, 57 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
25% less capital invested
Capital invested by funds: $1.21B → $907M (-$304M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
169
Holding in Top 10
2
Calls
$833K
Puts
$918K
Top Buyers
| 1 | +$6.62M | |
| 2 | +$5.94M | |
| 3 | +$5.47M | |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$3.53M |
| 5 |
LCM
Legato Capital Management
San Francisco,
California
|
+$3.32M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$9.21M | |
| 3 | -$4.39M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$4.2M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$3.86M |